Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2023-03-13 | New | $482,500 | $482,500 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| David Doyle | Director, Executive |
| Erik Eglite | Director, Executive |
| Charles Magolske | Director, Executive |
| Norbert Voelkel | Director |